Martin Pollak is a Nephrology physician affiliated with Broad Institute. OpenAlex indexes 295 publications with 23,581 citations (h-index 74); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
330 Brookline Ave
De 1
Boston, MA 022155400
Telephone
617-632-9880Registry record last updated 29 Sept 2011.
Clinical trials
- Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure
Sponsor: Beth Israel Deaconess Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20251 payment
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20241 payment
- Travere Therapeutics, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Metabolic Alkalinizer100%Potassium Citrate Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
18 NIH research awards on record, funded 1992–2026 per NIH RePORTER. The latest:
- APOL1 Nephropathy: Linking Genetics and Mechanisms
Beth Israel Deaconess Medical Center
FY2026$659,358R01DK145097 - INF2 in kidney function and dysfunction
Beth Israel Deaconess Medical Center
FY2026$632,384R01DK088826 - Integrating signals that control APOL1 gene expression and drive kidney disease
Beth Israel Deaconess Medical Center
FY2026$540,299R01DK138503
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Inaxaplin for Proteinuric Kidney Disease in Persons with Two <i>APOL1</i> Variants
New England Journal of Medicine
2023 - APOL1 Nephropathy: From Genetics to Clinical Applications
Clinical Journal of the American Society of Nephrology
2020 - APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases
Proceedings of the National Academy of Sciences
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Andrew Aguirre, MD, PhD
Broad Institute
Behnood Bikdeli, MD
Broad Institute
Janey Wiggs, MD
Broad Institute
Marios Giannakis, MD
Broad Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”